BRIEF published on 06/14/2024 at 22:50, 1 year 10 months ago Reminder Notice of Annual General and Special Meeting for Shareholders of Theralase® Shareholders Theralase® Virtual Meeting AGSM Zoom Presentation
PRESS RELEASE published on 06/14/2024 at 22:45, 1 year 10 months ago Reminder Notice of Annual General and Special Meeting for Shareholders of Theralase(R) Theralase Technologies Inc. provides a reminder for its Annual General and Special Meeting to be held on June 19th, 2024, with a virtual Zoom presentation including a Q&A session for shareholders Annual General Meeting Shareholders Theralase Technologies Inc. AGSM Virtual Zoom Presentation
BRIEF published on 06/12/2024 at 13:05, 1 year 10 months ago Rutherrin® Increases Efficacy of Chemotherapy Cancer Treatment Chemotherapy Rutherrin® Multidrug Resistance Theralase® Technologies
PRESS RELEASE published on 06/12/2024 at 13:00, 1 year 10 months ago Rutherrin(R) Increases Efficacy of Chemotherapy Theralase Technologies announces preclinical success of Rutherrin® in enhancing chemotherapy efficacy and reducing multidrug resistance in cancer cells Cancer Treatment Theralase Technologies Rutherrin® Multidrug Resistance Chemotherapy Efficacy
BRIEF published on 06/10/2024 at 13:05, 1 year 10 months ago Ruvidar(TM) Enhances Efficacy of Cancer Drug Cancer Treatment Theralase Technologies Ruvidar(TM) BCG NMIBC
PRESS RELEASE published on 06/10/2024 at 13:00, 1 year 10 months ago Ruvidar(TM) Enhances Efficacy of Cancer Drug Theralase® Technologies Inc. announces breakthrough in cancer research by developing RuBCG compound to enhance efficacy of bladder cancer treatment. Preclinical results show promising potential Theralase Technologies Inc. Cancer Research RuBCG Compound Bladder Cancer Treatment Preclinical Results
BRIEF published on 06/06/2024 at 13:05, 1 year 10 months ago Theralase Successfully Destroys Lung Cancer Preclinical Study Theralase Technologies Lung Cancer Rutherrin®
PRESS RELEASE published on 06/06/2024 at 13:00, 1 year 10 months ago Theralase(R) Successfully Destroys Lung Cancer Theralase® Technologies Inc. announces preclinical success with Rutherrin® compound in targeting Non-Small Cell Lung Cancer. Results show improved tumour destruction and slower progression Theralase Technologies Inc. Cancer Treatment Preclinical Study NSCLC Rutherrin Compound
BRIEF published on 06/04/2024 at 13:05, 1 year 11 months ago Theralase® Technology Effective in Virus Inactivation Theralase Ruvidar Antiviral Research Virus Inactivation Heliyon
PRESS RELEASE published on 06/04/2024 at 13:00, 1 year 11 months ago Theralase(R) Technology Effective in Virus Inactivation Theralase Technologies Inc. announces successful inactivation of various viruses with lead compound RuvidarTM through peer-reviewed research. Potential for viral vaccine development highlighted Theralase Technologies Inc. RuvidarTM Peer-Reviewed Research Viral Inactivation Viral Vaccine Development
Published on 05/04/2026 at 14:00, 1 minute ago CHAR Tech Appoints Infrastructure & Capital Markets Veteran Kevin Melnyk as CFO and Reminds Shareholders of Upcoming AGM
Published on 05/04/2026 at 13:30, 31 minutes ago Eskay Mining Corp. Contracts Apex Geoscience Ltd. For Its Summer Exploration Program Within the British Columbia Golden Triangle
Published on 05/04/2026 at 13:00, 1 hour 1 minute ago Eagle Plains and Xcite Expand Beaver River Uranium Project
Published on 05/04/2026 at 13:54, 7 minutes ago EQS-Adhoc: Borussia Dortmund publishes preliminary figures for the third quarter (Q3) of the 2025/2026 financial year
Published on 05/04/2026 at 13:35, 26 minutes ago DeFi Technologies Announces Shareholder Call to Discuss Q1 2026 Financial Results
Published on 05/04/2026 at 13:20, 40 minutes ago North Peak Resources Announces Agreement to Repurchase 1 Million Common Shares for Cancellation
Published on 05/04/2026 at 13:08, 53 minutes ago MEDICLIN increases group operating result in the first quarter
Published on 05/04/2026 at 12:40, 1 hour 21 minutes ago EQS-Adhoc: SOWITEC group GmbH and the Joint Representative enter into a deferral agreement regarding a partial repayment of the bond 2018/2026
Published on 05/04/2026 at 09:51, 4 hours 10 minutes ago GUILLEMOT CORPORATION: Weekly report share buyback From April 27th 2026 to May 1st 2026
Published on 05/04/2026 at 08:45, 5 hours 16 minutes ago Air Liquide divests its biogas production activities in four countries
Published on 04/30/2026 at 20:00, 3 days 18 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 3 days 18 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 3 days 19 hours ago Capital increase through exercise of subscription rights
